Covalon Technologies (CVALF) Projected to Post Quarterly Earnings on Thursday

Covalon Technologies (OTCMKTS:CVALF) is projected to post its results before the market opens on Thursday, December 11th. Analysts expect Covalon Technologies to post earnings of ($0.04) per share and revenue of $10.4860 million for the quarter.

Covalon Technologies Trading Up 0.9%

Shares of CVALF stock opened at $1.38 on Tuesday. Covalon Technologies has a 12-month low of $1.34 and a 12-month high of $2.69. The stock has a market capitalization of $38.12 million, a P/E ratio of 27.61 and a beta of 0.43. The firm’s 50 day moving average is $1.46 and its 200 day moving average is $1.66.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.